0120G0 · Samyang Biopharm Corporation
56200.00
KRWUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
n/a
PE
174.40
EV/EBITDA
65.7
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 20/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- Big Candle
- HALO All
Key Fundamentals
EPS 3 yr Growth
N/A
EBITDA Margin
19.70%
Operating Cashflow
₩9,774m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
15.80
Quick Ratio
1.30
Performance
52 weeks range
Low 23250 - 150900
Trade Value (12mth)
US$1,699,446.00
1 week
0%
1 month
41.38%
YTD
8.08%
1 year
0%
All time high
150900.00
Additional Data
Shares Outstanding (Fully Diluted)
7m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
KRW
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
Key Stakeholders
| Name | Title |
| Won Kim | Individual |
| Jeong Kim | Individual |
| Geon Ho Kim | Individual |
| Tae Ho Kim | Individual |
| Sudang Foundation | Foundation/Endowment |
